|
|
|
Insider
Information: |
Walbert Timothy P |
Relationship: |
Director |
City: |
Waukegan |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
131,514 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,120,342 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
131,514 |
|
|
Total
Value |
$3,120,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
Chairman, President an... |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
XOMA Corporation |
XOMA |
Director |
2016-07-21 |
129,314 |
2012-11-13 |
0 |
Premium* |
|
Egalet Corp |
EGLT |
Director |
2020-05-20 |
0 |
|
0 |
Premium* |
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2018-02-13 |
0 |
2016-06-02 |
0 |
Premium* |
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2024-04-01 |
2,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HZNP |
Horizon Pharma, Inc. |
President, Chairman and CEO |
|
2013-12-09 |
4 |
S |
$6.79 |
$82,322 |
D/D |
(12,124) |
148,497 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2020-02-01 |
4 |
D |
$34.49 |
$92,019 |
I/I |
(2,668) |
9,150 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Director |
|
2018-02-13 |
4 |
D |
$18.00 |
$92,340 |
D/D |
(5,130) |
0 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-01-05 |
4 |
D |
$73.28 |
$117,028 |
I/I |
(1,597) |
11,988 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-05-06 |
4 |
OE |
$22.14 |
$163,836 |
D/D |
7,400 |
467,949 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2014-12-08 |
4 |
D |
$12.99 |
$182,704 |
D/D |
(14,065) |
33,205 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2018-11-19 |
4 |
OE |
$2.40 |
$214,959 |
D/D |
49,801 |
595,871 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-02-01 |
4 |
D |
$77.04 |
$227,268 |
I/I |
(2,950) |
19,945 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2015-12-08 |
4 |
D |
$21.40 |
$324,809 |
D/D |
(15,178) |
203,706 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
President, Chairman and CEO |
|
2015-01-02 |
4 |
D |
$12.80 |
$337,318 |
D/D |
(26,353) |
88,527 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2018-01-02 |
4 |
D |
$15.02 |
$354,863 |
D/D |
(23,626) |
474,075 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-01 |
4 |
D |
$94.33 |
$355,341 |
I/I |
(3,767) |
40,923 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-02-17 |
4 |
D |
$87.17 |
$364,283 |
D/D |
(4,179) |
951,813 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-01-05 |
4 |
D |
$101.84 |
$370,290 |
I/I |
(3,636) |
35,603 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-05-11 |
4 |
OE |
$22.14 |
$389,664 |
D/D |
17,600 |
478,149 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
President, Chairman and CEO |
|
2014-05-19 |
4 |
AS |
$12.94 |
$410,741 |
D/D |
(31,742) |
148,930 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-12-31 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
529,482 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-01-14 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
699,222 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-01-28 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
710,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-11 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
610,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-25 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
610,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-03-11 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
560,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-03-25 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
560,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-04-08 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
510,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-04-22 |
4 |
OE |
$22.14 |
$553,500 |
D/D |
25,000 |
510,549 |
0 |
- |
|
160 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|